This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Moldovan, I R Articles by Pelfrey, C M Search for Related Content PubMed PubMed Citation Articles by Moldovan, I R Articles by Pelfrey, C M Social Bookmarking                         What's this?

Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing-remitting multiple sclerosis patients

Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH, USA

R A Rudick

Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH, USA, Department of Neurology (Mellen Center), Cleveland Clinic Foundation, Cleveland, OH, USA

A C Cotleur

Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH, USA

S E Born

Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH, USA

J-C Lee

Department of Biostatistics, Cleveland Clinic Foundation, Cleveland, OH, USA

M T Karafa

Department of Biostatistics, Cleveland Clinic Foundation, Cleveland, OH, USA

C M Pelfrey

Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH, USA, Case Western Reserve University, Institute of Pathology, Cleveland, OH, USA, pelfrec{at}ccf.org

The relationship between multiple sclerosis (MS) disease activity and myelin protein-induced cytokine responses over time is not elucidated. We addressed this relationship by examining longitudinal cytokine responses to myelin proteins every three months for one year, in the context of gadolinium (gad)-enhancing brain lesions and of clinical relapses. The ELISPOT assay was used to determine the ex vivo cytokine production in response to nine amino acid long peptides spanning the entire proteolipid protein (PLP) and myelin basic protein (MBP) molecules in relapsing—remitting (RR) MS patients and matched healthy controls. We identified three longitudinal levels of myelin-induced cytokine secretion by adding up the positive responses for all PLP or MBP peptides obtained for five timepoints, at three- month intervals: low reactivity (<200 cumulative cytokine-secreting cells), isolated peptide reactivity (201-450 cumulative cytokine- secreting cells) and recurrent protein-wide bursts of cytokine reactivity (> 451 cumulative cytokine-secreting cells). The majority of MS patients showed recurrent bursts to PLP and MBP. In contrast, controls showed a more even distribution between all levels of cytokine reactivity. The majority of patients with gad-enhancing lesions showed PLP/IFNg and MBP/IFNg recurrent burst responses. This is the first longitudinal study on MS patients in which nine amino acid long myelin peptides are used to reveal the broad range of PLP- and MBP- peptide cytokine reactivity across the whole molecule of these two major myelin proteins. This study also reveals the extremely dynamic nature of the immune reactivity to numerous regions of myelin, which can fluctuate dramatically over time. Such fluctuation could hamper the efficacy of antigen-based therapies for MS.

Key Words: ELISPOT • IFN • IL-10 • longitudinal cytokine reactivity • multiple sclerosis • myelin basic protein • proteolipid protein

Multiple Sclerosis, Vol. 11, No. 3, 251-260 (2005)
DOI: 10.1191/1352458505ms1165oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?